Search Results 801-810 of 16915 for monoclonal antibody
Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins; History or presence of other medical illness that indicates a ...
... monoclonal antibody and an immunomodulatory drug. * Must be naïve to treatment with ABBV-383. Exclusion Criteria: - Received B-cell maturation antigen (BCMA) ...
... monoclonal antibodies, antibody drug conjugates, radioimmunoconjugates, or T-cell orother cell-based therapies: 4 weeks (2 weeks permissible before the ...
Participants who have received any monoclonal antibody (other than Xolair) to treat inflammatory disease within 5 half-lives of visit 1; Participants who ...
Isatuximab is a monoclonal antibody that binds a specific epitope on the human CD38 receptor and has antitumour activity via multiple mechanisms of action.
Receipt of any monoclonal antibody treatment (within or outside a clinical trial) within 6 months before screening. Previously dosed with ALD403 or any ...
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org. Monoclonal antibody treatment can help high-risk ...
study drug. - Systemic cancer treatments, monoclonal antibody-directed therapies, other investigational agents within 4 weeks before enrollment, or <5 half ...
Prior severe infusion reaction to a monoclonal antibody. Severe, active co-morbidity, defined as follows: Significant history of uncontrolled cardiac ...
Known intolerance to CD20 monoclonal antibody therapy. History of primary central nervous system (CNS) lymphoma or CNS neoplastic disease. Platelet count ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.